(Q51825411)

13 April 2018

title

Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56. (English)

1 reference

13 April 2018

author

Per thor Straten

7

1 reference

13 April 2018

Mads Hald Andersen

8

object named as

Mads Hald Andersen

1 reference

13 April 2018

6

Jürgen C Becker

1 reference

13 April 2018

author name string

Rikke Baek Sørensen

1

1 reference

13 April 2018

Mikkel Faurschou

2

1 reference

13 April 2018

Lone Troelsen

3

1 reference

13 April 2018

David Schrama

4

1 reference

13 April 2018

Søren Jacobsen

5

1 reference

13 April 2018

language of work or name

English

0 references

publication date

12 February 2009

1 reference

13 April 2018

Journal of Investigative Dermatology

published in

1 reference

13 April 2018

volume

129

1 reference

13 April 2018

issue

8

1 reference

13 April 2018

page(s)

1992-1999

1 reference

13 April 2018

https://scigraph.springernature.com/pub.10.1038/jid.2009.10

exact match

0 references

cites work

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2009.10

1 reference

7 January 2021

Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Cytotoxic T lymphocytes and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Prognostic significance of hypopigmentation in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Candidate T cell epitopes of the human La/SSB autoantigen

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Peripheral blood in Sjögren's syndrome does not contain increased levels of T lymphocytes reactive with the recombinant Ro/SS-A 52 kD and La/SS-B 48 kD autoantigens.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

T cells in the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Livin, a novel inhibitor of apoptosis protein family member

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Is tumor immunity the same thing as autoimmunity? Implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Facilitating matched pairing and expression of TCR chains introduced into human T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Cooperation of Human Tumor-Reactive CD4+ and CD8+ T Cells after Redirection of Their Specificity by a High-Affinity p53A2.1-Specific TCR

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE)

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2009.10

7 January 2021

Identifiers

DOI

10.1038/JID.2009.10

1 reference

13 April 2018

PubMed ID

19212346

1 reference

13 April 2018